The Production Linked Incentive (PLI) Scheme for Pharmaceuticals was announced with a financial outlay of Rs 15,000 crore over a period of six years. It has attracted an overall investment of Rs 18,618.09 crore till March 2023, while the scheme for bulk drugs has seen investments of Rs 2405.09 crore and while medical devices sector has an investment of Rs 837.23 crore
PLI proves a key production impetus 27 July 2023 1:45 AM GMT
Tata Motors
Tata Motors to ramp up production 23 Jan 2022 8:26 PM GMT